NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA

Office for Artificial Intelligence UK Published: 2026-04-02 16:08:00

New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment

No full content stored. Use “Open Source” to read the original.

Open Source →

Recommended reads

Egg-cellent time for chatting with your kids about what they're seeing online this Easter From UK

As millions of children enjoy the Easter holidays, the government is stepping up to take the pressure off parents battling to keep their children safe online

Office for Artificial Intelligence · UK 2026-04-03

Policy paper: UK-US arrangement on pharmaceutical trade and pricing From UK

Shared UK and US commitments to improve access to medicines, support pharmaceutical innovation and grow trade in the life sciences sector.

Office for Artificial Intelligence · UK 2026-04-02

Guidance: Digital Assurance Playbook From UK

This playbook outlines changes to how the UK government manages digital and technology spending and assurance. The changes come into effect on 1 April 2026.

Office for Artificial Intelligence · UK 2026-04-01